Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 08:47:09 GMT 2023
by
admin
on
Sat Dec 16 08:47:09 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
3ZZ278643V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1509
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1233953-61-1
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
C152172
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
BC-118
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
3ZZ278643V
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
Refanezumab
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
CHEMBL3545317
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
10174
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
CHEMBL2109573
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY | |||
|
DB14908
Created by
admin on Sat Dec 16 08:47:09 GMT 2023 , Edited by admin on Sat Dec 16 08:47:09 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 2_22 | 2_96 |
| 3_23 | 3_94 |
| 4_23 | 4_94 |
| 3_139 | 3_199 |
| 4_139 | 4_199 |
| 1_153 | 1_209 |
| 2_153 | 2_209 |
| 1_229 | 3_219 |
| 2_229 | 4_219 |
| 1_235 | 2_235 |
| 1_238 | 2_238 |
| 1_270 | 1_330 |
| 2_270 | 2_330 |
| 1_376 | 1_434 |
| 2_376 | 2_434 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_306 |
| N | 2_306 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|